- Correction
- Open access
- Published:
Correction: Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
Journal of Inflammation volume 21, Article number: 45 (2024)
Correction to: Sun et al. Journal of Inflammation (2023) 20:37
After the publication of this article, it was reported that Fig. 3C & 4C contained errors. Specifically, the flow cytometric dot plots were incorrectly overlaid on the gating line in Fig. 3C & 4C. This phenomenon can be attributed to the improper manipulation and adjustment of layers during the use of Adobe Illustrator software to collate the flow cytometry results. Such actions led to the misalignment of cells and gating lines, thereby diminishing the accuracy of the displayed results. The authors promptly submitted the original data to the journal’s editorial office for verification, accompanied by the corrected images. The original article has been updated by the authors.
The corrected figures are as follows:
Corrected Figure 3
Effects of sodium butyrate on the T helper cell differentiation in EAMG mice. Mononuclear cells (MNCs) of the spleens and inguinal lymph nodes were isolated from mice in three groups on day 70. A Th1 cells, C Th17 cells, and E Treg cells were detected by flow cytometry. B The percentages of Th1, D Th17, and F Treg cells in MNCs were calculated. Data were from three independent experiments and expressed as mean±SEM. The significance of differences was assessed by ANOVA, followed by Tukey’s testing as a post-hoc test. (n = 3 mice/group), ns means not significant, *p < 0.005 and **p < 0.01
Corrected Figure 4
Efects of sodium butyrate on Tfh and B cell frequency and the representative cytokines and IgG antibodies levels. Mononuclear cells (MNCs) of the spleens were isolated from mice in three groups on day 70. A Tfh cells and C B cells were detected by fow cytometry. B The percentages of Tfh and D B cells in MNCs were calculated (n=3 mice/group). Levels of E IFN-γ, F IL-17 A, G IL-10, H IL-21, and I titer of IgG antibody in the blood were measured by ELISA (n=6 mice/group). Data were from three independent experiments and expressed as mean±SEM. The signifcance of diferences was assessed by ANOVA, followed by Tukey’s testing as a post-hoc test. ns means not signifcant, *p<0.05,**p<0.001
The Original Article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12950-023-00363-w.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Sun, J., Chen, J., Xie, Q. et al. Correction: Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response. J Inflamm 21, 45 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12950-024-00408-8
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12950-024-00408-8